A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
CStone Pharmaceuticals
CStone Pharmaceuticals
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Daiichi Sankyo
Novartis
Shanghai JMT-Bio Inc.
Merck Sharp & Dohme LLC
FBD Biologics Limited
InxMed (Shanghai) Co., Ltd.
BioNTech SE
Shanghai Runshi Pharmaceutical Technology Co., Ltd
NantCell, Inc.
Arog Pharmaceuticals, Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Gilead Sciences
Arog Pharmaceuticals, Inc.
Incyte Corporation
Eisai Inc.
Bayer
Mereo BioPharma
G1 Therapeutics, Inc.
AbbVie
Celgene
GlycoMimetics Incorporated
Eli Lilly and Company
ImmunoGen, Inc.
Amgen
Sanofi
La Jolla Pharmaceutical Company